Effect of retinoic acid on prostatic development

Prostate

Volumn 31, Issue 3, 1997, Pages 161-167

  Aboseif, Sherif R ^a   Dahiya, Rajvir ^a   Narayan, Perinchery ^a   Cunha, Gerald R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ductal branching; prostate development; retinoids

Indexed keywords

FENRETINIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; GROWTH STIMULATION; INHIBITION KINETICS; MALE; MATHEMATICAL COMPUTING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAMIN INTAKE;

ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENRETINIDE; GENE EXPRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTRETINOIN; MALE; ORGAN CULTURE TECHNIQUES; PROSTATE; RATS; RATS, INBRED F344; RECEPTORS, RETINOIC ACID; TESTOSTERONE; TRETINOIN; VIDEOTAPE RECORDING;

EID: 0031010546     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970515)31:3<161::AID-PROS3>3.0.CO;2-O     Document Type: Article

References (46)

1. Stepp W: Versuche über Futterung mit lipoidfreir Nahrung. Biochem Z 22:452-460, 1909.
2. Drummond JC: The nomenclature of the so called accessory food factors (vitamins). Biochem J 14:660-665, 1920.
3. Loeliger P, Bollag W, Mayer H: Arotinoids, a new class of highly active retinoids. Eur J Med Chem Ther 15:9-15, 1980.
4. Bollag W: Vitamin A and retinoids: From nutrition to pharmacotherapy in dermatology and oncology. Lancet 1:860-863, 1983.
5. Cunningham WJ, Ehmann CW: Clinical aspects of the retinoids. Semin Dermatol 2:145-160, 1983.
6. Fell HB, Mellanby E: Metaplasia produced in cultures of chick ectoderm by high vitamin A. J Physiol (Lond) 119:470-488, 1953.
7. Hardy MH: Glandular metaplasia of hair follicles and other responses to vitamin A excess in cultures of rodent skin. J Embryol Exp Morphol 19:157-180, 1968.
8. Lotan R, Lotan D, Sacks PG: Inhibition of tumor cell growth by retinoids. Methods Enzymol 190:100-110, 1990.
9. Wolbach SB, Howe PR: Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 43:753-777, 1925.
10. Hale F: Relation of vitamin A to anophthalmos in pigs. Am J Ophthalmol 18:1087-1093, 1935.
11. Hale F: Relation of maternal vitamin A deficiency to microphthalmia in pigs. Tex State J Med 33:228-232, 1937.
12. Lotan R, Nicolson GL: Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumor cells in vitro. JNCI 59:1717-1722, 1977.
13. Lippman SM, Kessler JF, Meyskens FL Jr: Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep 71:391-401, 1987.
14. Chopra DP, Wilkoff LJ: Reversal by vitamin A analogs (retinoids) of hyperplasia induced by N-methyl-N-nitro-N-nitrosoguanidine in mouse prostate organ cultures. JNCI 58: 923-930, 1977.
15. "Image Set Manual." Sunnyvale, CA: DappleSystem Inc., 1990, pp 81-83.
16. Eichele G: Retinoids and vertebrate limb pattern formation. Trends Genet 5:246-251, 1989.
17. Tickle C: Retinoic acid and chick limb bud development. Development [Suppl] 1:113-121, 1991.
18. Moon RC, McCormick DL, Mehta RG: Inhibition of carcinogenesis by retinoids. Cancer Res 43:2469-2475, 1983.
19. Meyskens FL Jr: Prevention and treatment of cancer with vitamin A and the retinoids. In Prasad K (ed): "Vitamins, Nutrition and Cancer." Basel: Karger, 1984, pp 266-289.
20. Lasnitzki I: Hypervitamin-A in the mouse prostate gland cultured in chemically defined medium. Exp Cell Res 28:40-51, 1962.
21. Lasnitzki I: Growth pattern of mouse prostate gland in organ culture and its response to sex hormones, vitamin A, and 3-methyl-cholanthrene. Natl Cancer Inst Monogr 12:381-403, 1963.
22. Lasnitzki I, Goodman DS: Inhibition of the effects of methylcholanthrene on mouse prostate in organ culture by vitamin A and its analogs. Cancer Res 34:1564-1571, 1974.
23. Pollard M, Luckert PH, Sporn MB: Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide. Cancer Res 51:3610-3611, 1991.
24. Mehta RG, Cerny WL, Moon RC: Retinoids inhibit prolactin-induced development of the mammary gland in vitro. Carcino-genesis 4:23-26, 1983.
25. Hultin TA, Filla M, McCormick D: Distribution and metabolism of the retinoid, N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice. Drug Metab Dispos 18:175-179, 1990.
26. Mehta RG, Hultin TA, Moon RC: Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl) retinamide by mammary gland in organ culture. Biochem J 256:579-584, 1988.
27. Russell DH, Haddox MK: Antiproliferative effects of retinoids related to the cell cycle-specific inhibition of ornithine decarboxylase. Ann NY Acad Sci 359:281-297, 1981.
28. Verma AK, Boutwell RK: Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res 37:2196-2201, 1977.
29. King LE Jr: What does epidermal growth factor do and how does it do it? J Invest Dermatol 84:165-167, 1985.
30. 1 on androgen-induced development of neonatal mouse seminal vesicles in vitro. Endocrinology 134:1155-1162, 1994.
31. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR: Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074-1078, 1994.
32. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL: Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6:2123-2128, 1992.
33. Story MT: Polypeptide modulators of prostatic growth and development. In Isaacs JT (ED): "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment." Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 199, pp 123-146.
34. Dahiya R, Park H-D, Cusick J, Vassella RL, Fournier G, Narayan P: Inhibition of tumorigenic potential and prostate specific antigen in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 59:126-132, 1994.
35. Mangelsdorf DJ, Evans RM: Retinoid receptors as transcription factors. In Yamamoto KR, McKnight SC (eds): "Transcriptional Regulation." Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1991, pp 210-230.
36. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229, 1990.
37. Petkovitch M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450, 1987.
38. Umesono K, Evans RM: Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57:1139-1141, 1989.
39. Giguere V, Lyn S, Yip P, Siu C-H, Amin S: Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein. Proc Natl Acad Sci USA 87:6233-6237, 1990.
40. Mangelsdorf DJ, Umesono K, Kleiwer SA, Borgmeyer U, Ong ES, Evans RM: A defect repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 6:555-561, 1991.
41. Heyman RA, Manglesdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406, 1992.
42. Moon RC, Itra LM: Retinoids and cancer. In Sporn MB, Roberts AB, Goodman DS (eds): "The Retinoids." Orlando, FL: Academic Press, 1984, pp 327-371.
43. Moon RC, Mehta RG: Cancer chemoprevention by retinoids: Animal models. Methods Enzymol 190:395-405, 1990.
44. Zile MH, Cullum ME, Roltsch IA: Effects of moderate vitamin A supplementation and lack of dietary vitamin A on the development of mammary tumors in female rats treated with low carcinogenic dose levels of 7,12 dimethylbenz(a)anthracene. Cancer Res 46:3495-3503, 1986.
45. Thompson HJ, Herbst EJ, Meeker LD: Chemoprevention of mammary carcinogenesis: A comparative review of the efficacy of polyamine antimetabolite, retinoids, and selenium. JNCI 77: 595-598, 1986.
46. Marth C, Mayer I, Daxenbichler G: Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem Pharmacol 33:2217-2221, 1984.